End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2625 USD | +1.94% |
|
-5.68% | -98.26% |
06-12 | Motion for Asset Sale Approved for Acorda Therapeutics, Inc. | CI |
05-14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |